compounders sue fda over ending semaglutide shortage 🚨 Moves to Shut Down Mass-Market Compounded GLP-1s The FDA is taking action to restrict widely marketed, non–FDA-approved compounded GLP-1 products, citing concerns safety, quality, and misleading claims. As demand FDA Ends Semaglutide Shortage Listing,

Isomers Skincare Glutathione Antioxidant Body Cream Offers & Perks ExtraFlex available when paying with the HSN Card or QCard

Consult your healthcare provider and the donation center for personalized advice

It is important to note that weight loss medications are not meant for long-term use alone and should be used in conjunction with a healthy lifestyle, including regular exercise and a balanced diet

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), which were initially approved for the treatment of type 2 diabetes (T2D) and obesity, have cardiovascular benefits that extend beyond glycaemic control

But MedisourceRx, which Hims & Hers had acquired in September 2024, did not report the problem to the FDA within 15 days after receiving the information as required by law